- Home
- PKG vs TEVA Comparison
PKG vs TEVA Comparison
Compare PKG & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKG
- TEVA
- Stock Information
- Founded
- PKG 1867
- TEVA 1901
- Country
- PKG United States
- TEVA Israel
- Employees
- PKG N/A
- TEVA N/A
- Industry
- PKG Containers/Packaging
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- PKG Consumer Discretionary
- TEVA Health Care
- Exchange
- PKG Nasdaq
- TEVA Nasdaq
- Market Cap
- PKG 20.4B
- TEVA 19.2B
- IPO Year
- PKG 2000
- TEVA N/A
- Fundamental
- Price
- PKG $229.22
- TEVA $21.20
- Analyst Decision
- PKG Buy
- TEVA Buy
- Analyst Count
- PKG 6
- TEVA 7
- Target Price
- PKG $241.20
- TEVA $21.00
- AVG Volume (30 Days)
- PKG 654.8K
- TEVA 11.3M
- Earning Date
- PKG 01-22-2025
- TEVA 01-29-2025
- Dividend Yield
- PKG 2.18%
- TEVA N/A
- EPS Growth
- PKG N/A
- TEVA N/A
- EPS
- PKG 8.58
- TEVA N/A
- Revenue
- PKG $8,175,100,000.00
- TEVA $16,772,000,000.00
- Revenue This Year
- PKG $8.24
- TEVA $4.70
- Revenue Next Year
- PKG $6.50
- TEVA $4.47
- P/E Ratio
- PKG $26.72
- TEVA N/A
- Revenue Growth
- PKG 4.24
- TEVA 9.81
- 52 Week Low
- PKG $159.57
- TEVA $10.34
- 52 Week High
- PKG $250.82
- TEVA $21.98
- Technical
- Relative Strength Index (RSI)
- PKG 31.34
- TEVA 75.06
- Support Level
- PKG $236.12
- TEVA $16.25
- Resistance Level
- PKG $240.73
- TEVA $17.72
- Average True Range (ATR)
- PKG 4.26
- TEVA 0.78
- MACD
- PKG -2.15
- TEVA 0.40
- Stochastic Oscillator
- PKG 0.53
- TEVA 86.39
About PKG Packaging Corporation of America
Packaging Corp. of America is the third-largest containerboard and corrugated packaging manufacturer in the United States. It produces over 4.5 million tons of containerboard annually. The company's share of the domestic containerboard market is roughly 10%. PCA differentiates itself from larger competitors by focusing on smaller customers and operating with a high degree of flexibility.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.